Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Menaquinone-4 (Vitamin K2)

Menaquinone-4 (Vitamin K2) (Synonyms: MK-4, Vitamin K2(20))

Catalog No.GC30258

Menaquinone-4 (Vitamin K2) is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.

Products are for research use only. Not for human use. We do not sell to patients.

Menaquinone-4 (Vitamin K2) Chemical Structure

Cas No.: 863-61-6

Size Price Stock Qty
10mM (in 1mL DMSO)
$39.00
In stock
100mg
$35.00
In stock
250mg
$56.00
In stock
1g
$162.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Menaquinone-4 is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.

Menaquinone-4 (MK-4, 0, 1, 5, 10 μM) increases the ALP activity in Caco-2 cells. Menaquinone-4 (1 μM) significantly increases intensities of hSI expression[1].

Menaquinone-4 (K2, 0.2 g/kg diet) in HF-K2 group produces epididymal fat in C57BL/6J mice, and also increases the bone density of mice[2].

[1]. Noda S, et al. Menaquinone-4 (vitamin K2) up-regulates expression of human intestinal alkaline phosphatase in Caco-2 cells. Nutr Res. 2016 Nov;36(11):1269-1276. [2]. Kim M, et al. Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice. J Clin Biochem Nutr. 2013 Sep;53(2):108-13.

Reviews

Review for Menaquinone-4 (Vitamin K2)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Menaquinone-4 (Vitamin K2)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.